Objectives: We sought to determine the proportion of false rifampicin resistant results using Xpert MTB/RIF version G4 on urine samples among HIV-infected inpatients investigated for TB. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,Īnd reproduction in any medium, provided the original work is properly cited.īackground: A small proportion of false rifampicin resistant results have previously been reported using GeneXpert MTB/RIF version G4 on sputum samples however, this has not been investigated for urine samples in HIV-associated tuberculosis (TB). Nicol, Liz Blumenthal, Graeme Meintjes, Andrew D. įalse rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patientsĬharlotte Schutz, Amy Ward, Rosie Burton, Mark P. False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients.
Kerkhoff Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California, San Francisco, United States Nicol Division of Medical Microbiology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa Liz Blumenthal Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM) and Department of Medicine, University of Cape Town, Cape Town, South Africa Graeme Meintjes Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM) and Department of Medicine, University of Cape Town, Cape Town, South Africa Andrew D. About the Author(s) Charlotte Schutz Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM) and Department of Medicine, University of Cape Town, Cape Town, South Africa Amy Ward Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM) and Department of Medicine, University of Cape Town, Cape Town, South Africa Rosie Burton GF Jooste Hospital Department of Medicine, University of Cape Town, Cape Town, South Africa Mark P.
0 kommentar(er)
